MENU
+Compare
MLSS
Stock ticker: ASE
AS OF
Nov 26 closing price
Price
$0.30
Change
-$0.01 (-3.23%)
Capitalization
23.82M

MLSS Milestone Scientific Forecast, Technical & Fundamental Analysis

Milestone Scientific Inc is a biomedical technology company... Show more

MLSS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for MLSS with price predictions
Nov 26, 2025

MLSS sees MACD Histogram just turned negative

MLSS saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on October 31, 2025. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 46 instances where the indicator turned negative. In of the 46 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MLSS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for MLSS entered a downward trend on November 26, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where MLSS's RSI Indicator exited the oversold zone, of 26 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 11 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

MLSS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. MLSS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.346) is normal, around the industry mean (9.206). P/E Ratio (0.000) is within average values for comparable stocks, (166.359). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.581). MLSS has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.016). P/S Ratio (2.753) is also within normal values, averaging (110.838).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MLSS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

View a ticker or compare two or three
MLSS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

MLSS is expected to report earnings to 0 cents per share on March 27

Milestone Scientific MLSS Stock Earnings Reports
Q4'25
Est.
$-0.01
Q3'25
Beat
by $0.01
Q2'25
Missed
by $0.01
Q1'25
Est.
$-0.02
Q4'24
Missed
by $0.01
The last earnings report on November 13 showed earnings per share of 0 cents, beating the estimate of -1 cents. With 504.08K shares outstanding, the current market capitalization sits at 23.82M.
A.I. Advisor
published General Information

General Information

a provider of subcutaneous injection technology for dental and medical applications

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
425 Eagle Rock Avenue
Phone
+1 973 535-2717
Employees
17
Web
https://www.milestonescientific.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RIG4.300.25
+6.17%
Transocean Ltd
ULCC4.440.26
+6.09%
Frontier Group Holdings
SDA2.100.08
+3.96%
SunCar Technology Group
ALNY445.1215.32
+3.56%
Alnylam Pharmaceuticals
CISO0.53N/A
-0.49%
CISO Global

MLSS and Stocks

Correlation & Price change

A.I.dvisor tells us that MLSS and ANGO have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MLSS and ANGO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLSS
1D Price
Change %
MLSS100%
-2.29%
ANGO - MLSS
28%
Poorly correlated
-0.81%
KRMD - MLSS
26%
Poorly correlated
+10.48%
ESTA - MLSS
26%
Poorly correlated
-1.43%
SRDX - MLSS
26%
Poorly correlated
N/A
QDEL - MLSS
25%
Poorly correlated
-2.26%
More

Groups containing MLSS

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLSS
1D Price
Change %
MLSS100%
-2.29%
Pharmaceuticals: Other
industry (103 stocks)
22%
Poorly correlated
+0.27%
Pharmaceuticals
industry (377 stocks)
19%
Poorly correlated
+1.17%